The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management
Colorectal cancer (CRC), classified as the third most prevalent cancer worldwide, remains to be a clinical and research challenge. It is estimated that ~50% of CRC patients die from distant metastases, with treatment of this complication still posing significant difficulties. While liver metastasis...
Main Authors: | Aldona Kasprzak, Agnieszka Adamek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3494 |
Similar Items
-
The Role of Biomarkers in the Management of Colorectal Liver Metastases
by: Daniel Brock Hewitt, et al.
Published: (2022-09-01) -
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases
by: Alexander R. Siebenhüner, et al.
Published: (2020-03-01) -
An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases
by: Ian S. Reynolds, et al.
Published: (2022-02-01) -
Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses
by: Antonio Mimmo, et al.
Published: (2022-03-01) -
Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases
by: Lucie Heczko, et al.
Published: (2023-11-01)